Intended for healthcare professionals


In brief

BMJ 2006; 332 doi: (Published 15 June 2006) Cite this as: BMJ 2006;332:1408

US licenses first cervical cancer vaccine: The US Food and Drug Administration has approved Merck's vaccine Gardasil. The vaccine protects against infection with human papillomavirus types 16 and 18, which cause about 70% of cervical, anal, and genital cancers, and against types 6 and 11, which cause about 90% of genital warts. It has caused controversy because of the recommendation that it …

View Full Text

Log in

Log in through your institution


* For online subscription